These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 22585292

  • 1. Cardiovascular failure, inotropes and vasopressors.
    Benham-Hermetz J, Lambert M, Stephens RC.
    Br J Hosp Med (Lond); 2012 May; 73(5):C74-7. PubMed ID: 22585292
    [No Abstract] [Full Text] [Related]

  • 2. A Review of Inotropes and Inopressors for Effective Utilization in Patients With Acute Decompensated Heart Failure.
    Nandkeolyar S, Ryu R, Mohammad A, Cordero-Caban K, Abramov D, Tran H, Hauschild C, Stoletniy L, Hilliard A, Sakr A.
    J Cardiovasc Pharmacol; 2021 Sep 01; 78(3):336-345. PubMed ID: 34117179
    [Abstract] [Full Text] [Related]

  • 3. Levosimendan with other inotropes or vasopressors: Should you combine them?
    Cunha GJL, Rocha BML, Gomes RV, Ferraz M, Fernandes L, Morais R, Campos L, Araújo I, Fonseca C.
    Am J Emerg Med; 2020 Dec 01; 38(12):2723-2726. PubMed ID: 32278570
    [No Abstract] [Full Text] [Related]

  • 4. Inotropes and vasopressors in adults and foals.
    Corley KT.
    Vet Clin North Am Equine Pract; 2004 Apr 01; 20(1):77-106. PubMed ID: 15062460
    [Abstract] [Full Text] [Related]

  • 5. [Vasopressors and inotropes: use in paediatrics].
    García-Canales A, Peña-Juárez RA, Sandoval-Franco LM.
    Arch Cardiol Mex; 2018 Apr 01; 88(1):39-50. PubMed ID: 28336302
    [Abstract] [Full Text] [Related]

  • 6. The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials.
    Belletti A, Castro ML, Silvetti S, Greco T, Biondi-Zoccai G, Pasin L, Zangrillo A, Landoni G.
    Br J Anaesth; 2015 Nov 01; 115(5):656-75. PubMed ID: 26475799
    [Abstract] [Full Text] [Related]

  • 7. Cardiogenic shock: Inotropes and vasopressors.
    Amado J, Gago P, Santos W, Mimoso J, de Jesus I.
    Rev Port Cardiol; 2016 Dec 01; 35(12):681-695. PubMed ID: 27836218
    [Abstract] [Full Text] [Related]

  • 8. Considerations for Inotrope and Vasopressor Use in Critically Ill Patients With Pulmonary Arterial Hypertension.
    Adie SK, Abdul-Aziz AA, Ketcham SW, Moles VM.
    J Cardiovasc Pharmacol; 2022 Jan 01; 79(1):e11-e17. PubMed ID: 34654789
    [Abstract] [Full Text] [Related]

  • 9. Pressors and inotropes.
    Kanter J, DeBlieux P.
    Emerg Med Clin North Am; 2014 Nov 01; 32(4):823-34. PubMed ID: 25441037
    [Abstract] [Full Text] [Related]

  • 10. Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit.
    Jentzer JC, Coons JC, Link CB, Schmidhofer M.
    J Cardiovasc Pharmacol Ther; 2015 May 01; 20(3):249-60. PubMed ID: 25432872
    [Abstract] [Full Text] [Related]

  • 11. Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease.
    Overgaard CB, Dzavík V.
    Circulation; 2008 Sep 02; 118(10):1047-56. PubMed ID: 18765387
    [No Abstract] [Full Text] [Related]

  • 12. Outcomes of cardiopulmonary resuscitation for patients on vasopressors or inotropes: a pilot study.
    Grigoriyan A, Vazquez R, Palvinskaya T, Bindelglass G, Rishi A, Amoateng-Adjepong Y, Manthous CA.
    J Crit Care; 2009 Sep 02; 24(3):415-8. PubMed ID: 19427759
    [Abstract] [Full Text] [Related]

  • 13. Intermittent inotropes for advanced heart failure: inquiring minds want to know.
    Silver MA.
    Am Heart J; 1999 Aug 02; 138(2 Pt 1):191-2. PubMed ID: 10426825
    [No Abstract] [Full Text] [Related]

  • 14. Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents?
    Cleland JG.
    Br J Hosp Med; 1999 Aug 02; 52(5):193, 195-6. PubMed ID: 7820314
    [No Abstract] [Full Text] [Related]

  • 15. [Pharmacotherapy of acute heart failure: update and perspectives].
    Link A, Pöss J, Böhm M.
    Dtsch Med Wochenschr; 2012 May 02; 137(21):1126-9. PubMed ID: 22588659
    [Abstract] [Full Text] [Related]

  • 16. Vasopressors and Inotropes in Sepsis.
    Stratton L, Berlin DA, Arbo JE.
    Emerg Med Clin North Am; 2017 Feb 02; 35(1):75-91. PubMed ID: 27908339
    [Abstract] [Full Text] [Related]

  • 17. [Chronic cardiac insufficiency: current treatment and future outlook].
    Reuge L, Metzger J, Burri M, Kehtari R.
    Rev Med Suisse Romande; 1996 Jun 02; 116(6):441-50. PubMed ID: 8711295
    [No Abstract] [Full Text] [Related]

  • 18. Review and update on inotropes and vasopressors.
    Cooper BE.
    AACN Adv Crit Care; 2008 Jun 02; 19(1):5-13; quiz 14-5. PubMed ID: 18418098
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rational use of inotropic therapy in heart failure.
    Felker GM, O'Connor CM.
    Curr Cardiol Rep; 2001 Mar 02; 3(2):108-13. PubMed ID: 11177666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.